Skip to content
10-Q

Quarterly Report

CELLYNX GROUP, INC.

0001017386-13-000052

← back to feed
Filed
Feb 19, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Feb 14, 2013 1.46B sh
Shares Diluted Q1 2013 · Dec 31, 2012 2B sh
Shares Diluted Q1 2013 · Dec 31, 2011 212.01M sh
Operating Cash Flow Q1 2013 · Dec 31, 2012 −$6.1K
Operating Cash Flow Q1 2013 · Dec 31, 2011 −$5.69K
Stockholders Equity Q1 2013 · Dec 31, 2012 −$3.47M
Stockholders Equity Q1 2013 · Sep 30, 2012 −$4.37M
Current Liabilities Q1 2013 · Dec 31, 2012 $3.52M
Current Liabilities Q1 2013 · Sep 30, 2012 $4.42M
Total Liabilities Q1 2013 · Dec 31, 2012 $3.52M
Total Liabilities Q1 2013 · Sep 30, 2012 $4.42M
Current Assets Q1 2013 · Dec 31, 2012 $14
Current Assets Q1 2013 · Sep 30, 2012 −$284
Total Assets Q1 2013 · Dec 31, 2012 $49.47K
Total Assets Q1 2013 · Sep 30, 2012 $49.81K
Eps Diluted Q1 2013 · Dec 31, 2012 $0.00
Eps Diluted restated Q1 2013 · Dec 31, 2011 −$0.00
Eps Basic Q1 2013 · Dec 31, 2012 $0.00
Eps Basic restated Q1 2013 · Dec 31, 2011 −$0.00
Sga Expense Q1 2013 · Dec 31, 2012 $138.31K
Sga Expense Q1 2013 · Dec 31, 2011 $155.5K
Rd Expense Q1 2013 · Dec 31, 2012 $39K
Net Income Q1 2013 · Dec 31, 2012 $902.12K
Net Income Q1 2013 · Dec 31, 2011 −$164.29K
Operating Income Q1 2013 · Dec 31, 2012 −$177.31K
Operating Income Q1 2013 · Dec 31, 2011 −$155.5K